
Carmignac Portfolio Emergents: Letter from the fund manager
In 2024, Carmignac Portfolio Emergents posted a performance of +5.5% (F EUR Acc share class - ISIN LU0992626480), compared with +14.7% for its reference indicator (MSCI Emerging Markets Index USD, net dividends reinvested)1.
2024 Review
2024 was a bad year for the Emerging Equities asset class, which underperformed developed markets for the fourth consecutive year.
Against this backdrop, the underperformance of the Fund vs. its indicator is mainly due to 3 factors:
- Exposure to Latin America
- Positioning in China
- The disappointing performance of Samsung Electronics in Korea
The fund suffered from its exposure to Latin America (20% of the fund's net assets as of 31/12/2024), particularly Brazil and Mexico. After the invasion of Ukraine in early 2022, Brazilian and Mexican assets performed very well for two years. In 2024, however, they were penalized by political issues, which are often the Achilles' heel of countries in this region. After the sell-off, our Brazilian assets are very attractively valued, like our investments in electricity concessions, which offer yields of up to 21% in Brazilian real, even though inflation is around 5%2.
As for Mexico, we were penalized by the weakness of the bank Grupo Banorte, as well as the industrial property company Vesta, both of which suffered from the sell-off of Mexican markets following the judicial reform adopted by the new president Claudia Sheinbam, and the uncertainties surrounding the US elections and their impact on the Mexican economy. However, Claudia Sheibaum has shown her willingness to work with the US administration to preserve the economic interests of both countries, which we believe will help the rebound of Mexican assets given that the economy has decent fundamentals.
As for China, although the Chinese markets performed relatively well in 2024, our stock selection contributed negatively to performance. Indeed, in 2024, the market was driven upwards by index heavyweights Tencent, Meituan and state-owned banks. We avoid leaders with dominant market shares such as Tencent or Meituan, due to the Chinese government's stated desire to promote competition by avoiding dominant positions. And we exclude all state-owned companies whose corporate governance leads to conflicts of interest which, in the long run, are usually unfavorable to minority investors. It should be noted that our stock selection in China has been a major driver of performance over the past 5 years (contribution of 57% vs -9% for the Chinese stocks of the index)3 and that 2024 is therefore an exception. After the strong rebound of Chinese markets following the economic stimulus announcements in October 2024, we reduced our Chinese exposure to 23.4% of the Fund, focusing on our strongest convictions.
Finally, the Fund suffered from the disappointing performance of Samsung Electronics. The stock declined primarily due to the weakness of the DRAM / NAND cycle4 and also due to the fact that its competitor SK Hynix, gained market share thanks to its lead in the sophisticated memory chip manufacturing (HBM products), further diminishing Samsung's share value despite its strong financial performance earlier in the year. We were also disappointed by our holdings in Hyundai Motor and LG Chem during the period.
However, worth highlighting, the solid rebound of our Taiwanese technology stocks (TSMC, Elite Material) and our Indian positions (ICICI Lombard, Kotak) recorded excellent performances, underpinning the Fund's performance in 2024.
Outlook & Positioning
After 2024, a year marked by the underperformance of emerging markets relative to US markets, we remain constructive on EM equities because we believe current valuations reflect a very pessimistic scenario, which we do not adhere to. We believe that the economic decoupling between the US and China will not have the negative consequences expected by the market. China's exports to the US account for ~13% of total Chinese exports. China's exports to the US account for no more than 13% of total Chinese exports. And every year, China moves a little closer to total autonomy in all areas, including the strategic field of high technology.
In China, after having an in-line exposure over the whole year, we trimmed aggressively in mid-October after the big rally that happened after the announcements of stimulus. We maintain a measured allocation to China with an underweight positioning versus our reference indicator. We are maintaining a significant allocation to India, where the long-term outlook remains promising. However, stretched valuations and technical factors call for a more selective approach.
We continue to have significant exposure to the AI theme, and we increased our exposure to this theme with the addition of the world leading Korean semiconductor company SK Hynix, specialized in manufacturing the most sophisticated memory chips.
After a difficult 2024 marked by political problems, we remain constructive on our Latin America. We believe that Brazilian assets are very attractively valued, like our investments in electricity concessions (Eletrobras), which offer yields of up to 21% in Brazilian real. As for Mexico, the markets suffered from fears over the judicial reform carried out by the new president Claudia Sheinbaum and then by the election of Trump, But Claudia Sheibaum has recently shown a willingness to work with the US administration to preserve the economic interests of both countries, which gives us cause for optimism for 2025.
More generally, we are maintaining a concentrated portfolio with balanced exposure, combining quality, high-visibility stocks (Asian tech stocks, India) with companies trading at very attractive valuations (China, Brazil).
1Past performance is not necessarily indicative of future performance. Performances are net of fees (excl. possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations. The fund presents a risk of capital loss.
2Sources: Company data, Bloomberg, 31/12/2024.
3Sources: Carmignac, MSCI, Bloomberg. Returns of Carmignac Emergents’ Chinese stocks versus the returns of MSCI EM’s Chinese stocks from 31/12/2019 to 31/12/2024.
4DRAM: Dynamic Random Access Memory, NAND: flash memory (NOT AND).

Carmignac Portfolio Emergents
Carmignac Portfolio Emergents F EUR Acc
- Aanbevolen minimale beleggingstermijn*
- 5 jaar
- Risicoschaal**
- 4/7
- SFDR-fondscategorieën***
- Artikel 9
*Aanbevolen minimale beleggingstermijn: Dit deelnemingsrecht/deze klasse is mogelijk niet geschikt voor beleggers die voornemens zijn hun inleg voor afloop van de aanbevolen termijn op te nemen. Deze verwijzing naar een beleggersprofiel is geen beleggingsadvies. Welk bedrag redelijkerwijs in een ICBE kan worden belegd hangt af van uw persoonlijke situatie en moet worden bekeken in relatie tot uw totale portefeuille. **Het profiel kan variëren van 1 tot 7, waarbij categorie 1 overeenkomt met een lager risico en een lager potentieel rendement, en categorie 7 met een hoger risico en een hoger potentieel rendement. De categorieën 4, 5, 6 en 7 impliceren een hoge tot zeer hoge volatiliteit, met grote tot zeer grote prijsschommelingen die op korte termijn tot latente verliezen kunnen leiden. ***De Sustainable Finance Disclosure Regulation (SFDR) 2019/2088. De SFDR-classificatie van de fondsen kan in de loop van de tijd veranderen.
Voornaamste risico's van het Fonds
Kosten
- Instapkosten
- Wij brengen geen instapkosten in rekening.
- Uitstapkosten
- Wij brengen voor dit product geen uitstapkosten in rekening.
- Beheerskosten en andere administratie - of exploitatiekos ten
- 1,15 % van de waarde van uw belegging per jaar. Dit is een schatting op basis van de feitelijke kosten over het afgelopen jaar.
- Prestatievergoedingen
- 20,00 % wanneer het rendement van de aandelenklasse over de prestatieperiode hoger is dan dat van de referentie-indicator. Deze prestatievergoeding is ook verschuldigd als de aandelenklasse beter
heeft gepresteerd dan de referentie-indicator, maar een negatief rendement heeft behaald. Een eventuele minderprestatie wordt
over een periode van 5 jaar goedgemaakt. Het feitelijke bedrag zal
variëren naargelang van de prestaties van uw belegging. De schatting van de totale kosten hierboven omvat het gemiddelde over de afgelopen vijf jaar, of sinds de introductie van het product als dat minder dan vijf jaar geleden is
- Transactiekosten
- 0,39 % van de waarde van uw belegging per jaar. Dit is een schatting van de kosten die ontstaan wanneer we de onderliggende beleggingen voor het product kopen en verkopen. Het feitelijke bedrag zal variëren naargelang hoeveel we kopen en verkopen.
- Roerende voorheffing
- ─
- Roerende voorheffing bij verkoop
- ─
- Taks op beursverrichtingen (TOB)
- 1.32% (max.4000 €)
- Conversiekosten
- 0%
Rendement
| Carmignac Portfolio Emergents | +16,5 | +23,6 | +5,5 | +9,8 | −14,3 | −10,3 | +44,9 | +25,5 | −18,2 | +19,8 |
| Referentie-indicator | +19,4 | +17,8 | +14,7 | +6,1 | −14,9 | +4,9 | +8,5 | +20,6 | −10,3 | +20,6 |
| Carmignac Portfolio Emergents | +16,9 % | +6,1 % | +8,0 % |
| Referentie-indicator | +20,1 % | +7,7 % | +8,0 % |
Bron: Carmignac op 30 okt. 2026.
Het beheer van dit deelnemingsrecht/deze klasse is niet gebaseerd op de indicator. In het verleden behaalde resultaten en waarden bieden geen garantie voor toekomstige resultaten en waarden. De vermelde rendementen zijn netto na aftrek van alle kosten, met uitzondering van eventuele in- en uitstapkosten, en worden verkregen na aftrek van kosten en belastingen die van toepassing zijn op een gemiddelde detailhandelsklant die als natuurlijke persoon woonachtig is in België. Wanneer de valuta afwijkt van uw eigen valuta, bestaat er een valutarisico dat kan resulteren in een waardedaling. De referentievaluta van het fonds/subfonds is de EUR. Het fonds houdt een risico op kapitaalverlies in.
Het rendement kan stijgen of dalen als gevolg van valutaschommelingen voor de aandelen die niet valutadekkend zijn.
Referentie-indicator: MSCI EM NR index
![[Management Team] [Author] Hovasse Xavier](https://carmignac.imgix.net/uploads/NextImage/0001/18/%5BManagement-Team%5D-%5BAuthor%5D-Hovasse-Xavier-1.png?auto=format%2Ccompress&fit=fill&w=3840)